MedPath

se Of Beejpushti Rasa in treatment of low sperm count.

Phase 4
Conditions
Health Condition 1: N461- OligospermiaHealth Condition 2: N538- Other male sexual dysfunction
Registration Number
CTRI/2022/03/041380
Lead Sponsor
MS Shree Dhootapapeshwar Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Male participants aged 22 to 40 years.

2.Participants having history of infertility since last 1 year and seeking management for the same.

3.Participants with history of regular sexual intercourse with sexually normal female partner.

4.Sperm count below 15 million/ml on two occasions separated by at least 1 week duration.

5.Body Mass Index lower than 35 kg/m2

6.Participants willing to give specimen of semen before and at the end of the study.

7.Participants willing to give written informed consent.

Exclusion Criteria

1.History of Testicular mal descent, previous reproductive organ surgery, Sexually Transmitted Diseases, HIV/ AIDS, varicocele, hydrocele, hypertension.

2.Participants with a history of mumps, measles, small pox, chicken pox, tuberculosis.

3.Participants with history of Diabetes mellitus, Thyroid disorders, and any other major systemic disease, injury to genitalia or metabolic disorders.

4.Participants with history of psychiatric illness.

5.Participants giving history of addiction to drug, tobacco or alcohol.

6.Participants receiving or having received any infertility treatment for the past 1 month and any other treatment being received simultaneously that may influence the study.

7.Participation in another clinical trial or receipt of any investigational medicinal product in the past 3 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the effect of Beejpushti Rasa on sperm count increase in participants with oligospermia after 90 days of treatment as compared to the baseline.Timepoint: Sperm count increase in participants after 90 days of treatment as compared to the baseline.
Secondary Outcome Measures
NameTimeMethod
1.To study the effect of Beejpushti Rasa on sperm count and morphological characteristics of sperm i.e. normal forms, live forms, motility etc. after 90 days of treatment as compared to the baseline. <br/ ><br>2.To study the effect of Beejpushti Rasa on serum testosterone levels after 90 days of treatment as compared to the baseline. <br/ ><br>3.To assess the safety of Beejpushti Rasa with respect to haematological parameters like Complete Blood Count (CBC), Liver Function Test (LFT) [AST, ALT, S. Bilirubin], Renal Function Test (RFT) [BUN and S. Creatinine], Fasting Plasma Glucose (FPG) and Urine Routine and Microscopy after completion of 90 days of treatment <br/ ><br>Questionnaire based subjective evaluation of sexual parameters including sexual desire, erectile dysfunction and ejaculatory function, overall satisfaction and frequency of coitus after 45 days and 90 days of treatment as compared to the baseline.Timepoint: Baseline after 90 days of treatment as compared to the baseline.
© Copyright 2025. All Rights Reserved by MedPath